NCT01441063 2020-10-27Tocilizumab for KSHV-Associated Multicentric Castleman DiseaseNational Institutes of Health Clinical Center (CC)Phase 2 Completed8 enrolled 18 charts
NCT01024036 2018-03-21A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's DiseaseJanssen Research & Development, LLCPhase 2 Completed79 enrolled 20 charts